Live Quote · NASDAQSCNIHealthcare· Biotechnology

Scinai Immunotherapeutics Ltd.

$0.27 0.59%($-0.00)
TickerSpark Score
56/100
Mixed
100
Valuation
20
Profitability
55
Growth
76
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SCNI research report →

52-Week Range1% of range
Low
$0.24
Current
$0.27
High
$3.48
Company Overviewwww.scinai.com

About the company

Scinai Immunotherapeutics Ltd. operates as an emerging biopharmaceutical company, dedicated to the research, production, and market introduction of medical solutions. Based in Israel, its primary objective is the prevention and treatment of a range of infectious, autoimmune, and other health conditions.

CEO
Amir Reichman
IPO
2015
Employees
31
HQ
Jerusalem, IL

Price Chart

-88.09% · this period
$2.34$1.30$0.25Jul 02Dec 31Jul 02
Valuation
Market Cap
$355.68K
P/E
0.00
P/S
0.25
P/B
0.00
EV/EBITDA
-0.10
Div Yield
0.00%
Profitability
Gross Margin
-221.32%
Op Margin
-573.87%
Net Margin
-188.87%
ROE
-30.05%
ROIC
-53.23%
Growth & Income
Revenue
$1.31M · 99.24%
Net Income
$-8,307,000 · -273.21%
EPS
$-3.60 · -160.00%
Op Income
$-7,542,000
FCF YoY
4.60%
Performance & Tape
52W High
$3.48
52W Low
$0.24
50D MA
$0.46
200D MA
$0.84
Beta
2.11
Avg Volume
3.55M

Get TickerSpark's AI analysis on SCNI

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 16, 26GERMAIN MARKother120,000,000
Jun 16, 26Reichman Amirother400,000,000
Mar 18, 26Mark Eladother0
Mar 18, 26Mark Eladother13,460,984
Mar 18, 26MARGOLIN YAELother200,000
Mar 18, 26MARGOLIN YAELother8,000,000
Mar 18, 26MARGOLIN YAELother48,200,000
Mar 18, 26Ben-Or Uriother0
Mar 18, 26Ben-Or Uriother2,519,344
Mar 18, 26Moed Samuel Jother200,000
Coverage · SCNI

Our SCNI coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on SCNI yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate SCNI report →
Internal Compare

Similar companies

Peers in the same neighborhood.